Retina Institute of California in Arcadia has announced that it now offers the genetic test for age-related macular degeneration RetnaGene.
RetnaGene is designed to evaluate the risk of patients with AMD progressing to advanced chorodial neovascular disease.
More Articles on Ophthalmology:
Dr. David Risner Joins Heaton Eye Associates in Texas
Geneva Eye Clinic Partners With Foundation Fighting Blindness
US Commerce Association Recognizes Dr. Jonathan Frantz, Frantz EyeCare